A US Senate subcommittee hearing examined potential links between COVID-19 vaccines and aggressive cancers, with experts ...
A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and ...
The findings of trials using intismeran, an mRNA-based individualised vaccine, was published at the 2026 annual meeting of ...
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
Share on Pinterest A personalized vaccine and Keytruda combination shows durable response against melanoma over 5 years. Image credit: Luis Velasco/Stocksy A phase 2b clinical trial suggests a ...
Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
Researchers delivered GM-CSF mRNA to the endometrium using targeted nanoparticles. Implantation was restored in injured mouse ...
Scientists from China have developed a new broad-spectrum mRNA vaccine that could provide long-term protection against the ...
The same mRNA technology behind COVID-19 vaccines may soon supercharge your annual flu shot. A major clinical trial finds an experimental mRNA flu vaccine cuts confirmed flu illness by about 27 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results